EFFECTS OF CITALOPRAM, A SYNTHETIC SEROTONIN UPTAKE INHIBITOR, ON INDOLEAMINE AND CATECHOLAMINE CONCENTRATIONS IN THE CEREBROSPINAL-FLUID OF FREELY MOVING RATS
H. Tohgi et al., EFFECTS OF CITALOPRAM, A SYNTHETIC SEROTONIN UPTAKE INHIBITOR, ON INDOLEAMINE AND CATECHOLAMINE CONCENTRATIONS IN THE CEREBROSPINAL-FLUID OF FREELY MOVING RATS, Journal of neural transmission. Parkinson's disease and dementia section, 9(2-3), 1995, pp. 111-119
We studied changes in the concentrations of 5-hydroxytryptamine (5-HT)
, other indoleamines, and catecholamines in the cerebrospinal fluid (C
SF) of freely-moving rats that had been administered citalopram, +/- 1
-[3-(Dimethylamino)propyl]-1-(4-fluorophentyl)-1, 3-dihydro-5-isobenzo
furancarbonitrile hydrobromide), a selective inhibitor of 5-HT uptake.
In a microdialysis experiment, the intracerebral extracellular free 5
-HT increased significantly, peaking 60 to 90 min after citalopram (30
mg/kg p.o.) was administerd. The 5-HT concentrations in CSF from the
cisterna magna increased significantly, reaching a maximum 6 hours aft
er a single dose of citalopram (30 mg/kg p.o.) was given. Six hours af
ter this dose, the CSF 5-HT concentration in the cisterna magna was si
gnificantly increased, and the 5-hydroxyindoleacetic acid (5-HIAA) con
centration was significantly decreased. There were non-significant cha
nges in the other indoleamines (tryptophan, 5-hydroxytryptophan, and k
ynurenine) and in the catecholamines (dopamine, homovanillic acid, nor
metanephrine, and 3-methoxy-4-hydroxyphenethyleneglycol). The 5-HT/try
ptophan ratio was correlated significantly with the kynurenine/tryptop
han ratio before treatment with citalopram (r = 0.81, p = 0.051), indi
cative that there is coordination of the serotonin and kynurenine path
ways in normal rats. In the animals posttreatment there was no such co
rrelation, suggesting that the changes in 5-HT are independent of the
kynurenine system at least within the 6 hours postreatment. These CSF
results appear to reflect selective inhibition of 5-HT uptake in brain
tissues by citalopram that is not associated with changes in catechol
amines.